Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, with a primary focus on neuromuscular diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:ALBPS.
$16.50 +0.07 (0.43%)
As of 02/26/2021 10:57:53 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.